GSK

Glaxo Said to Sell 2.5 Billion Euros of Bonds as Rates Fall
Bloomberg
Tue, 11/25/14 - 01:36 pm
GSK
bonds
GSK shareholders to vote on Novartis deal on Dec. 18
Yahoo/Reuters
Mon, 11/24/14 - 09:39 am
GSK
Novartis
cancer
consumer health
vaccines
M&A
Clovis taps GlaxoSmithKline to team up on lung cancer
Fierce Biotech
Tue, 11/18/14 - 11:51 am
Clovis
GSK
non-small cell lung cancer
Mekinist
rociletinib
No safety concerns yet in trials of GSK's Ebola vaccine
Yahoo/Reuters
Mon, 11/17/14 - 08:34 am
GSK
ebola virus
clinical trials
vaccines
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
Ebola Contracts Worth $2 Billion Could Benefit Drugmakers
Bloomberg
Mon, 11/10/14 - 10:58 am
ebola virus
JNJ
GSK
[video] Treat Sickness as Biodefense Threat: GlaxoSmithKline CEO
Bloomberg
Fri, 11/7/14 - 08:49 am
GSK
biodefense drugs
Andrew Witty
GlaxoSmithKline's effort to relaunch cancer R&D faces skepticism
Bloomberg
Fri, 11/7/14 - 07:44 am
GSK
R&D
GSK hepatitis C shot shows promise, bodes well for Ebola vaccines
Yahoo/Reuters
Wed, 11/5/14 - 07:33 pm
GSK
vaccines
ebola virus
hepatitis C
Glaxo files regulatory submissions for asthma drug candidate
Seeking Alpha
Wed, 11/5/14 - 09:31 am
GSK
asthma
Europe
mepolizumab
Pharma's top 10 M&A deals of 2014's first half
Fierce Pharma
Mon, 11/3/14 - 08:57 am
M&A
Actavis
Forest Labs
GSK
Novartis
Bayer
Merck
Mallinckrodt
Questcor Pharmaceuticals
Eli Lilly
Idenix
Nestle
Galderma
Sun Pharma
Ranbaxy
Aptalis
Abbott Labs
CFR
In Ebola Crisis, New Vaccine Candidates Show Uncertain Promise
Forbes
Wed, 10/29/14 - 08:59 am
ebola virus
vaccines
Novavax
GSK
JNJ
Ebola: The making of a $1 billion drug
CNN Money
Tue, 10/28/14 - 10:29 am
ebola virus
GSK
NewLink Genetics
JNJ
government contracts
Bavarian Nordic
Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?"
Forbes
Fri, 10/24/14 - 07:35 am
vaccines
ebola virus
R&D
clinical trials
GSK
GSK restructures, as respiratory disappoints
Medical Marketing and Media
Thu, 10/23/14 - 09:52 am
GSK
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Fierce Biotech
Wed, 10/22/14 - 08:32 am
GSK
ViiV Healthcare
IPOs
HIV
Pfizer
J&J, GSK ready to collaborate on Ebola vaccine work
Yahoo/Reuters
Wed, 10/22/14 - 07:57 am
JNJ
GSK
ebola virus
vaccines
GSK Q3 revenue disappoints with 3% fall to $8.9B
CNBC
Wed, 10/22/14 - 07:54 am
GSK
earnings
Ebola Vaccine Trials Carry Risks for Companies in Chase
Bloomberg
Tue, 10/21/14 - 08:12 am
ebola virus
vaccines
GSK
JNJ
NewLink Genetics
Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe?
Yahoo/Zacks.com
Mon, 10/20/14 - 06:34 pm
GSK
China
bribery
earnings

Pages